N. Matsumoto

Restoration of immune responses in tumor-bearing mice by ONO-4007, an antitumor lipid A derivative.

Norihito Matsumoto, Y. Aze, T. Fujita, 1997, Immunopharmacology.

ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.

Y. Aze, T. Fujita, N. Matsumoto, 1998, The Journal of pharmacology and experimental therapeutics.

Synthesis of the key intermediate, diethyl 2-acetylamino-2-(2-(4-octanoylphenyl)ethyl)propane-1,3-dioate, of the immunomodulatory agent FTY720 (fingolimod).

T. Fujita, S. Sasaki, N. Matsumoto, 2008, Chemical & pharmaceutical bulletin.

Preparation of antibodies against a novel immunosuppressant, FTY720, and development of an enzyme immunoassay for FTY720.

K. Watabe, T. Kohno, T. Fujita, 2006, Bioorganic & medicinal chemistry.

Intratumoral tumor necrosis factor induction and tumor growth suppression by ONO-4007, a low-toxicity lipid A analog.

Y. Aze, H. Oida, T. Fujita, 1998, Anticancer Research.